{"id":"https://openalex.org/W2590103753","doi":"https://doi.org/10.1200/jco.2011.29.15_suppl.2546","title":"A phase I study of once-weekly aminoflavone prodrug (AFP464) in solid tumor patients.","display_name":"A phase I study of once-weekly aminoflavone prodrug (AFP464) in solid tumor patients.","publication_year":2011,"publication_date":"2011-05-20","ids":{"openalex":"https://openalex.org/W2590103753","doi":"https://doi.org/10.1200/jco.2011.29.15_suppl.2546","mag":"2590103753"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2011.29.15_suppl.2546","doi":"https://doi.org/10.1200/jco.2011.29.15_suppl.2546","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2011.29.15_suppl.2546","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5008665323","display_name":"Matthew Philip Goetz","orcid":"https://orcid.org/0000-0002-4383-270X","observed_orcids":["https://orcid.org/0000-0002-4383-270X","https://orcid.org/0000-0003-3588-024X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. P. Goetz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027416118","display_name":"Joel M. Reid","orcid":"https://orcid.org/0000-0003-2872-3123","observed_orcids":["https://orcid.org/0000-0003-2872-3123"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. M. Reid","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083309726","display_name":"Yingwei Qi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Y. Qi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014307565","display_name":"A. Chen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Chen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110580704","display_name":"Renee M. McGovern","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. M. McGovern","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110666944","display_name":"Mary J. Kuffel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. J. Kuffel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"P. D. Scanlon","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P. D. Scanlon","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022511085","display_name":"Charles Erlichman","orcid":"https://orcid.org/0000-0002-1687-7080","observed_orcids":["https://orcid.org/0000-0002-1687-7080"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C. Erlichman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5066722006","display_name":"Matthew M. Ames","orcid":"https://orcid.org/0000-0003-3652-209X","observed_orcids":["https://orcid.org/0000-0003-3652-209X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. M. Ames","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":16,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"29","issue":"15_suppl","first_page":"2546","last_page":"2546"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12356","display_name":"Bioactive Compounds and Antitumor Agents","score":0.4081999957561493,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12356","display_name":"Bioactive Compounds and Antitumor Agents","score":0.4081999957561493,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.28690001368522644,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.17649999260902405,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.6010000109672546},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.7559999823570251},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9309999942779541},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.921999990940094},{"id":"https://openalex.org/keywords/cyp1a1-induction","display_name":"CYP1A1 induction","score":0.8799999952316284},{"id":"https://openalex.org/keywords/dna-alkylation","display_name":"DNA alkylation","score":0.6759999990463257},{"id":"https://openalex.org/keywords/pulmonary-toxicity","display_name":"pulmonary toxicity","score":0.7179999947547913},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.6850000023841858},{"id":"https://openalex.org/keywords/thrombocytopenia","display_name":"thrombocytopenia","score":0.8820000290870667},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.6819999814033508},{"id":"https://openalex.org/keywords/advanced-cancer","display_name":"advanced cancer","score":0.49300000071525574},{"id":"https://openalex.org/keywords/tumor-biopsy","display_name":"tumor biopsy","score":0.38999998569488525},{"id":"https://openalex.org/keywords/thrombosis","display_name":"thrombosis","score":0.3880000114440918}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.794318437576294},{"id":"https://openalex.org/C16020263","wikidata":"https://www.wikidata.org/wiki/Q1778553","display_name":"DLCO","level":5,"score":0.7171803712844849},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6752973794937134},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.5468267798423767},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.5223994255065918},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.4795379638671875},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.47218528389930725},{"id":"https://openalex.org/C2777513400","wikidata":"https://www.wikidata.org/wiki/Q104219","display_name":"Bilirubin","level":2,"score":0.46264350414276123},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4513135254383087},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4343600869178772},{"id":"https://openalex.org/C2781442060","wikidata":"https://www.wikidata.org/wiki/Q425745","display_name":"Bendamustine","level":4,"score":0.43309009075164795},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.3783314824104309},{"id":"https://openalex.org/C165637977","wikidata":"https://www.wikidata.org/wiki/Q11067835","display_name":"Diffusing capacity","level":4,"score":0.37090006470680237},{"id":"https://openalex.org/C2777714996","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung","level":2,"score":0.28209438920021057},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.08835864067077637},{"id":"https://openalex.org/C3018587741","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung function","level":3,"score":0.0},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2011.29.15_suppl.2546","doi":"https://doi.org/10.1200/jco.2011.29.15_suppl.2546","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2011.29.15_suppl.2546","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W154097633","https://openalex.org/W3081465473","https://openalex.org/W2058177773","https://openalex.org/W2941778486","https://openalex.org/W2285631403","https://openalex.org/W1874269299","https://openalex.org/W2603723827","https://openalex.org/W2129316505","https://openalex.org/W2576256214","https://openalex.org/W2574638291"],"abstract_inverted_index":{"2546":[0],"Background:":[1],"AFP464":[2,146,269,286],"(NSC":[3],"710464)":[4],"is":[5,288,337,358],"a":[6,45,74,141,154,182,241,251,291,345],"lysyl":[7],"derivative":[8],"of":[9,60,73,143,173,184,294,335],"aminoflavone":[10],"metabolized":[11],"by":[12,140,153,160,368],"cytochrome":[13],"P450":[14],"(CYP)1A1":[15],"and":[16,38,58,71,92,104,147,157,212,221,270,313,323,373],"CYP1A2":[17],"(Kuffel":[18],"et":[19],"al,":[20],"Mol":[21],"Pharmacol":[22],"62:143,":[23],"2002)":[24],"to":[25,49,94,196,258,307],"reactive":[26],"species":[27],"that":[28],"covalently":[29],"bind":[30],"DNA,":[31],"with":[32,80,100,231,290],"preclinical":[33],"activity":[34],"in":[35,77,229,240,305,344,351],"breast,":[36],"renal,":[37],"ovarian":[39],"cell":[40],"lines.":[41],"Methods:":[42],"We":[43],"performed":[44,88],"phase":[46,348],"I":[47],"study":[48,245,350],"define":[50],"the":[51,164,279],"maximally":[52],"tolerated":[53],"dose":[54,191,253,284,359],"(MTD),":[55],"pharmacokinetics":[56],"(pk)":[57],"pharmacodynamics":[59],"AFP-464":[61,312,336],"when":[62],"given":[63],"as":[64],"an":[65],"infusion":[66],"on":[67],"days":[68],"1,":[69,247],"8,":[70],"15":[72],"28-day":[75],"cycle":[76,90],"patients":[78],"(pts)":[79],"advanced":[81],"solid":[82],"tumors.":[83],"Pulmonary":[84,356],"function":[85,106],"tests":[86],"were":[87,107,110,151,169,201,267,273],"during":[89],"1":[91],"prior":[93],"subsequent":[95],"cycles.":[96],"Advanced":[97],"cancer":[98],"pts":[99,180,205,277],"good":[101],"performance":[102],"status":[103],"organ":[105],"eligible.":[108],"DLTs":[109,200],"grade":[111,114,119,136,207,216,222],"4":[112,217,223],"neutropenia,":[113],"3":[115,120,144,204,208],"thrombocytopenia":[116],"or":[117],"\u2265":[118],"non-hematologic":[121],"toxicities":[122],"including":[123,206],"carbon":[124],"monoxide":[125],"diffusing":[126],"capacity":[127],"(DLCO).":[128],"An":[129],"accelerated":[130],"titration":[131],"design":[132],"was":[133,238,261],"used":[134],"until":[135],"2":[137,185],"toxicity,":[138],"followed":[139],"cohorts":[142],"design.":[145],"AF":[148,271,302,314],"plasma":[149],"concentrations":[150],"measured":[152],"lc/ms/ms":[155],"assay":[156],"pk":[158,272],"determined":[159],"non-compartmental":[161],"analysis.":[162],"At":[163],"MTD,":[165],"paired":[166],"tumor":[167,174,265],"biopsies":[168],"obtained":[170],"for":[171,275,311],"analysis":[172],"CYP1A1":[175,362],"induction.":[176],"Results:":[177],"24":[178],"evaluable":[179],"received":[181],"median":[183],"cycles":[186],"(range":[187,318,326],"1-8)":[188],"across":[189],"7":[190],"levels":[192],"ranging":[193],"from":[194],"10":[195,280],"74":[197,259,282],"mg/m2.":[198],"Five":[199],"observed":[202,239],"among":[203],"AST,":[209],"Alk":[210],"Phos,":[211],"bilirubin":[213],"(14":[214],"mg/m2),":[215,220],"thrombosis":[218],"(53":[219],"DLCO":[224,230],"(>":[225],"5":[226],"unit":[227],"drop":[228],"pneumonitis)":[232],"(74":[233],"mg/m2).":[234],"Because":[235],"pulmonary":[236],"toxicity":[237,357],"European":[242],"AFP":[243],"464":[244],"(day":[246],"8":[248],"schedule)":[249],"at":[250],"similar":[252],"level":[254],"(68":[255],"mg/m2/week),":[256],"accrual":[257],"mg/m2":[260,283,339],"terminated":[262],"early.":[263],"No":[264],"responses":[266],"observed.":[268],"characterized":[274],"27":[276],"over":[278],"\u2013":[281,299,320,328],"range.":[285],"clearance":[287],"linear":[289],"mean":[292],"value":[293],"259":[295],"L/h/m2":[296],"(range,":[297],"143":[298],"444":[300],"L/h/m2).":[301],"exposure":[303],"increased":[304],"proportion":[306],"dose.":[308],"Half-life":[309],"values":[310],"are":[315,365],"5.6":[316],"h":[317,325],"(0.2":[319],"25.3":[321],"h)":[322],"3.4":[324],"(0.9":[327],"7.0":[329],"h),":[330],"respectively.":[331],"Conclusions:":[332],"The":[333],"MTD":[334],"53":[338],"which":[340],"will":[341],"be":[342],"studied":[343],"CTEP":[346],"sponsored":[347],"II":[349],"ER":[352],"positive":[353],"breast":[354],"cancer.":[355],"limiting.":[360],"Tumor":[361],"biomarker":[363],"studies":[364],"ongoing.":[366],"Supported":[367],"NCI":[369],"U01":[370],"(CA69912),":[371],"MM01-RR00585":[372],"Tigris":[374],"Pharmaceuticals.":[375]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":3},{"year":2023,"cited_by_count":2},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2017-03-03T00:00:00"}